FDA Approved: RADIOGARDASE — Supplemental Application (Heyl Chem.-pharm. Fabrik GmbH & Co. KG)

View source ↗

Summary

FDA approved a supplemental application for Radiogardase (prussian blue insoluble capsules) by Heyl Chem.-pharm. Fabrik GmbH & Co. KG under NDA021626.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesium-137 Poisoning
• Thallium Poisoning

Drugs mentioned

• Radiogardase (Prussian blue insoluble capsules)

Snippet

SUPPL AP for RADIOGARDASE (PRUSSIAN BLUE INSOLUBLE CAPSULES)